PHARMA MEDICO ApS
Core data
Name | PHARMA MEDICO ApS |
Address | Hans Hartvig Seedorffs Stræde 12, 8000, Aarhus C |
Founded | Jul 4, 2006 |
Employees (CVR) | 9 |
Locations (P-units) | 2View locations |
Website | https://pharmamedico.com/ |
Branch | Fremstilling af farmaceutiske råvarer (211000) |
Name | PHARMA MEDICO ApS |
Address | Hans Hartvig Seedorffs Stræde 12, 8000, Aarhus C |
Founded | Jul 4, 2006 |
Employees (CVR) | 9 |
Locations (P-units) | 2View locations |
Website | https://pharmamedico.com/ |
Branch | Fremstilling af farmaceutiske råvarer (211000) |
Keep track of PHARMA MEDICO ApS
Description
Pharma Medico Group is a family-controlled, privately held global group focused on research, development, production, and marketing of clinically documented dermatological therapies and related products and technologies.
The group develops and markets effective, clinically documented products for dermatological disorders, including hair growth disorders, age- and sun-damaged skin, psoriasis, eczema, and dermatitis. Its work is based on ongoing research and patented ingredients, products, and technologies.
Company's own description on virk.dk
Selskabets hovedaktivitet er at drive virksomhed med udvikling, produktion og salg af dermatologiske produkter, handelsvirksomhed, investeringsvirksomhed, handel med værdipapirer og anden dermed beslægtet virksomhed samt enhver aktivitet, der efter direktionens skøn står i forbindelse hermed.
Products & services
Nourkrin® · Nourella® · Zymbilan® · Proteoglycan Replacement Therapy · Proprietary delivery technologies · Products and therapies for hair growth disorders · Products and therapies for age- and sun-damaged skin · Products and therapies for psoriasis, eczema, and dermatitis
Industries
Dermatological healthcare · Research and development · Pharmaceutical and therapeutic product manufacturing
Customer types
Dermatologists · Trichologists · Health care professionals · In-licensing and distribution partners · Retail chains
Financials
| Reporting period | 2025DKK | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross profit | 32,265,731 | ||||||||
| Operating profit | 20,270,170 | ||||||||
| Profit before tax | 19,929,171 | ||||||||
| Net income | 15,407,736 | ||||||||
| Total assets | 78,959,410 | ||||||||
| Equity | 63,546,192 | ||||||||
| Avg. employees | 10 | ||||||||
2017–2025 Unlock financial history | |||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Contact
From cvr.dk
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Morten Christensen | Roles Management | TitlesDIREKTØR |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Deloitte Statsautoriseret Revisionspartnerselskab | AuditorKristian Bredgaard Lassen | RoleStatsautoriseret revisor | FromJun 15, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
Foreign legal entity | Ownership90–99.99 % | Voting rights90 % | FromNov 24, 2021 |
| Ownership10–14.99 % | Voting rights10 % | FromJan 1, 2009 |
Child companies
| Company | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership100 % | Voting rights100 % | FromNov 1, 2017 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇬🇧Pharma Medico UK Limited | Ownership through Direct | 90–99.99 % |
| Gitte Damgaard Sloth | Ownership through | 9–14.99 % |